Skip to main content
SpringerLink
Log in

Koronare Herzkrankheit

  • Chapter
Pharmakotherapie

Part of the book series: Springer-Lehrbuch ((SLB))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • Abernethy DR, Schwartz JB (1999) Calcium-antagonist drugs. N. Engl. J. Med. 341: 1447–1457

    Article  PubMed  CAS  Google Scholar 

  • Anderson HV, Willerson JT (1993) Thrombolysis in acute myocardial infarction. N. Engl. J. Med. 329: 703–709

    Article  PubMed  CAS  Google Scholar 

  • Antiplatelet Trialist’s Collaboration (1994) The Aspirin papers. Brit. Med. J. 308:71–72; 81–106; 159–168; 235–246

    Google Scholar 

  • Braunwald E, Califf RM, Cannon ChrP et al. (2000) Redefining medical treatment in the management of unstable angina. Am. J. Med. 108: 41–53

    Article  PubMed  CAS  Google Scholar 

  • CRIS (1996) A controlled trial of verapamil in patients after acute myocardial infarction — results of the calcium antagonist reinfarction italian study. CRIS (Calcium Antagonist Antagonist Reinfarction Italian Study). Am. J. Cardiol. 77: 365–369

    Article  Google Scholar 

  • EUROASPIRE I and II Group (2001) Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 257: 995–1001

    Google Scholar 

  • Fears R (1990) Biochemical pharmacology and therapeutic aspects of thrombolytic agents. Pharmacol. Rev. 42: 201–222

    PubMed  CAS  Google Scholar 

  • Furberg CD, Psaty BM, Meyer JV (1995) Nifedipine — dose-related increase in mortality in patients with coronary heart disease. Circulation 92:1326–1331

    PubMed  CAS  Google Scholar 

  • GISSI-3 (1994) Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. GISSI-3 (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico). Lancet 343: 1115–1122

    Google Scholar 

  • GISSI-Prevenzione-Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin Eafter myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447–455

    Article  Google Scholar 

  • Gottlieb StS, McCarter RJ, Vogel RA (1998) Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N. Engl. J. Med. 339: 489–497

    Article  PubMed  CAS  Google Scholar 

  • Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hagan V, Lee BK, Hlatky MA (1999) Meta-analysis of trials comparing ?-blockers, calcium antagonists, and nitrates for stable angina. JAMA 281: 1927–1936

    Article  PubMed  CAS  Google Scholar 

  • Hennekens CH, Albert CM, Godfried SL, Gaziano JM, Buring JE (1996) Adjunctive drug therapy of acute myocardial infarction-evidence from clinical trials. N. Engl. J. Med. 335: 1660–1667

    Article  PubMed  CAS  Google Scholar 

  • ISIS-2 (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: Lancet 2(8607): 349–360

    Google Scholar 

  • ISIS-4 (1995) A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 345: 669–685

    Google Scholar 

  • Lange RA, Cigarroa RG, Yancy Jr CW, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD (1989) Cocaine-induced coronary-artery vasoconstriction. N. Engl. J. Med. 321: 1557–1562

    Article  PubMed  CAS  Google Scholar 

  • Langenfeld H (1993) β-Rezeptorenblocker bei frischem Myokardinfarkt. Dtsch. Med. Wochenschr. 118: 1569–1574

    Article  PubMed  CAS  Google Scholar 

  • LaRosa JC, He J, Vupputuri S (1999) Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials. JAMA 282: 2340–2346

    Article  PubMed  CAS  Google Scholar 

  • Parker JD, Parker JO (1998) Nitrate therapy for stable angina pectoris. N. Engl. J. Med. 338: 520–531

    Article  PubMed  CAS  Google Scholar 

  • Pfeffer MA, Braunwald E, Moye LA et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 327: 669–677

    Article  PubMed  CAS  Google Scholar 

  • Pfeffer MA, McMurray JJV, Velazquez EJ et al (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N. Engl. J. Med. 349: 1893–1906

    Article  PubMed  CAS  Google Scholar 

  • Pfeffer MA, Swedberg K, Granger CB et al. (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall Programme. Lancet 362: 759–766

    Article  PubMed  CAS  Google Scholar 

  • Schrör K (1992) Acetylsalicylsäure. Thieme Stuttgart — New York

    Google Scholar 

  • Schrör K, Hohlfeld Th (1990) Koagulation, Thrombose und Fibrinolyse bei myokardialer Ischämie. In: Heusch G (Hrsg) Pathophysiologie und rationale Pharmakotherapie der Myokardischämie. Steinkopff, Darmstadt, S 89–117

    Google Scholar 

  • Sleight P (1996) Calcium antagonists during and after myocardial infarction [review]. Drugs 51: 216–225

    PubMed  CAS  Google Scholar 

  • Swedburg K, Held P, Kjekshus J. et al (1992) Effects of early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative North Scandinavian Enalapril Survival Study II (Consensus II). N. Engl. J. Med. 327: 678–684

    Article  Google Scholar 

  • The GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N. Engl. J. Med. 329: 673–682

    Article  Google Scholar 

  • The Infarction Ramipril Efficacy (AIRE) Study Investigators (1994) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821–828

    Google Scholar 

  • Topol EJ, Byzova TV, Plow EF (1999) Platelet GPIIb/IIIa blockers. Lancet 353:227–231

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225, Düsseldorf

    Prof. Dr. med. K. Schrör

  2. Klinik für Kardiologie Pneumologie und Angiologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225, Düsseldorf

    Prof. Dr. M. Kelm

Authors
  1. Prof. Dr. med. K. Schrör
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. M. Kelm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Schrör, K., Kelm, M. (2004). Koronare Herzkrankheit. In: Pharmakotherapie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35149-3_16

Download citation

  • DOI: https://doi.org/10.1007/3-540-35149-3_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20414-5

  • Online ISBN: 978-3-540-35149-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation